1. Home
  2. GKOS vs SNAP Comparison

GKOS vs SNAP Comparison

Compare GKOS & SNAP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Glaukos Corporation

GKOS

Glaukos Corporation

N/A

Current Price

$177.33

Market Cap

10.9B

Sector

Health Care

ML Signal

N/A

Logo Snap Inc.

SNAP

Snap Inc.

HOLD

Current Price

$5.48

Market Cap

9.2B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
GKOS
SNAP
Founded
1998
2010
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Computer Software: Programming Data Processing
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
10.9B
9.2B
IPO Year
2015
2017

Fundamental Metrics

Financial Performance
Metric
GKOS
SNAP
Price
$177.33
$5.48
Analyst Decision
Strong Buy
Hold
Analyst Count
12
26
Target Price
$126.92
$8.41
AVG Volume (30 Days)
580.7K
30.3M
Earning Date
04-29-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
35.71
EPS
N/A
N/A
Revenue
$507,442,000.00
$824,949,000.00
Revenue This Year
$23.32
$15.55
Revenue Next Year
$27.43
$9.82
P/E Ratio
N/A
N/A
Revenue Growth
32.33
103.95
52 Week Low
$73.16
$3.81
52 Week High
$191.62
$9.28

Technical Indicators

Market Signals
Indicator
GKOS
SNAP
Relative Strength Index (RSI) 55.85 60.01
Support Level $175.04 $5.46
Resistance Level $184.00 $5.82
Average True Range (ATR) 5.63 0.32
MACD -1.97 0.01
Stochastic Oscillator 30.42 72.77

Price Performance

Historical Comparison
GKOS
SNAP

About GKOS Glaukos Corporation

Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. The company has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.

About SNAP Snap Inc.

Snap is a technology company best known for its marquis social media application, Snapchat, a visual messaging application that has amassed hundreds of millions of users. The app was initially only used to communicate with family and friends through photographs and short videos (known as "Snaps"). Users can now enjoy augmented reality, or AR, lenses, content from famous creators and celebrities, updates about local events, and more. Although the app offers a paid subscription option with premium features, advertising sales produce most of the app's revenue. The firm also sells wearable devices called AR Spectacles, which can capture photos and videos overlayed with AR lenses, but these make up a small portion of Snap's overall sales.

Share on Social Networks: